Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
Highlighting its Proprietary INTASYL siRNA Therapeutic Platform and Development Update for Lead PH-762 Program in Cutaneous Squamous Cell Carcinoma Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, October 5, 2026 / …